Spero Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 0 |
| FY2017 | 14.4M |
| FY2018 | 17.2M |
| FY2019 | 19.2M |
| FY2020 | 29.3M |
| FY2021 | 30.9M |
| FY2022 | 37.6M |
| FY2023 | 53.0M |
| FY2024 | 54.0M |
| FY2025 | 59.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2016 | 0 |
| FY2017 | 14.4M |
| FY2018 | 17.2M |
| FY2019 | 19.2M |
| FY2020 | 29.3M |
| FY2021 | 30.9M |
| FY2022 | 37.6M |
| FY2023 | 53.0M |
| FY2024 | 54.0M |
| FY2025 | 59.0M |